Alphabet Launches Isomo To Advance AI Drug Discovery

Alphabet announced on Nov. 5, 2021 that it is launching a new company, Isomo, to apply DeepMind’s artificial intelligence to pharmaceutical research. The unit will focus on discovering new drugs, developing tools and processes, and exploring AI-driven discovery methods. The move signals Alphabet’s strategic push into biotech and computational drug discovery.